Nothing Special   »   [go: up one dir, main page]

NO20061711L - 4-((fenoksylalkyl)tio)fenoksyeddiksyre og analoger - Google Patents

4-((fenoksylalkyl)tio)fenoksyeddiksyre og analoger

Info

Publication number
NO20061711L
NO20061711L NO20061711A NO20061711A NO20061711L NO 20061711 L NO20061711 L NO 20061711L NO 20061711 A NO20061711 A NO 20061711A NO 20061711 A NO20061711 A NO 20061711A NO 20061711 L NO20061711 L NO 20061711L
Authority
NO
Norway
Prior art keywords
phenoxyalkyl
thio
analogs
phenoxyacetic acid
dyslipidemia
Prior art date
Application number
NO20061711A
Other languages
English (en)
Other versions
NO337041B1 (no
Inventor
Gee-Hong Kuo
Philip S Johnson
Rui Zhang
Aihua Wang
Alan R Deangelis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34392924&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20061711(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20061711L publication Critical patent/NO20061711L/no
Publication of NO337041B1 publication Critical patent/NO337041B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Indole Compounds (AREA)

Abstract

Oppfinnelsen tilveiebringer en forbindelse: 4-((fenoksyalkyl)tio)-fenoksyeddiksyre og analoger, forbindelser som inneholder dem og fremgangsmåter for anvendelse av dem som PPAR-deltamodulatorer for å behandle eller inhibere progresjonen av for eksempel dyslipidemi.
NO20061711A 2003-09-19 2006-04-19 4-((fenoksyalkyl)tio)-fenoksyeddiksyrer og analoger, farmasøytisk preparat samt anvendelse av forbindelsene NO337041B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50408903P 2003-09-19 2003-09-19
PCT/US2004/030188 WO2005030694A1 (en) 2003-09-19 2004-09-16 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

Publications (2)

Publication Number Publication Date
NO20061711L true NO20061711L (no) 2006-06-19
NO337041B1 NO337041B1 (no) 2016-01-11

Family

ID=34392924

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061711A NO337041B1 (no) 2003-09-19 2006-04-19 4-((fenoksyalkyl)tio)-fenoksyeddiksyrer og analoger, farmasøytisk preparat samt anvendelse av forbindelsene

Country Status (31)

Country Link
US (4) US7598292B2 (no)
EP (2) EP1670744B9 (no)
JP (1) JP5016922B2 (no)
KR (1) KR101094742B1 (no)
CN (1) CN1882524B (no)
AR (1) AR045774A1 (no)
AT (1) ATE476408T1 (no)
AU (1) AU2004276231B2 (no)
BR (1) BRPI0414534B8 (no)
CA (1) CA2539403C (no)
CO (1) CO5680473A2 (no)
CR (1) CR8303A (no)
CY (2) CY1110847T1 (no)
DE (1) DE602004028500D1 (no)
DK (2) DK2243766T3 (no)
EA (1) EA009119B1 (no)
EC (1) ECSP066435A (no)
ES (2) ES2349143T3 (no)
HK (1) HK1093060A1 (no)
HU (1) HUE028213T2 (no)
IL (1) IL174399A (no)
NO (1) NO337041B1 (no)
NZ (1) NZ545971A (no)
PL (2) PL2243766T3 (no)
PT (2) PT2243766E (no)
SG (1) SG149041A1 (no)
SI (2) SI2243766T1 (no)
TW (1) TWI330630B (no)
UA (1) UA87468C2 (no)
WO (1) WO2005030694A1 (no)
ZA (1) ZA200603084B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7301050B2 (en) 2003-09-19 2007-11-27 Janssen Pharmaceutical N.V. 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
MY147518A (en) * 2004-09-15 2012-12-31 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
MY145712A (en) * 2004-09-15 2012-03-30 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JO3006B1 (ar) * 2005-09-14 2016-09-05 Janssen Pharmaceutica Nv املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
UY30288A1 (es) * 2006-04-18 2007-08-31 Janssen Pharmaceutica Nv Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol
AU2011296737A1 (en) 2010-08-31 2013-04-11 Snu R&Db Foundation Use of the fetal reprogramming of a PPAR delta agonist
CN103183612A (zh) * 2011-12-30 2013-07-03 北大方正集团有限公司 二丙基丙二酸二酯的制备方法
US9073943B2 (en) 2012-02-10 2015-07-07 Lupin Limited Antiviral compounds with a dibenzooxaheterocycle moiety
CN106188097B (zh) * 2016-07-08 2018-01-05 郑州大学 一种3‑氯甲基氧头孢烯类抗生素母核的制备方法
PT3522880T (pt) * 2016-10-05 2021-02-22 Mitobridge Inc Métodos de tratamento de lesão renal aguda

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125732A (en) * 1977-05-06 1978-11-14 American Cyanamid Company 2-Aryloxy-2-(phenoxyalkoxy)phenyl acetic acid and esters
DE3169761D1 (en) 1981-01-09 1985-05-09 Fisons Plc Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them
JPS58177934A (ja) 1982-04-13 1983-10-18 Takeda Chem Ind Ltd ベンゾキノン誘導体
ATE22072T1 (de) 1982-09-30 1986-09-15 Merck Frosst Canada Inc Leukotrienantagonisten, deren herstellung und diese enthaltende zusammensetzungen.
US4820867A (en) * 1983-04-21 1989-04-11 Merck Frosst Canada, Inc. Phenoxypropoxy halophenylacetic acids as leukotriene antagonists
JPS61268651A (ja) * 1985-05-23 1986-11-28 Takeda Chem Ind Ltd フエニル酢酸誘導体およびその製造法
US5726165A (en) * 1994-07-29 1998-03-10 Smithkline Beecham P.L.C. Derivatives of 4-(2-aminoethyl)phenoxymethyl-phosphonic and -phosphinic acid and pharmaceutical and veterinary uses therefor
AU712607B2 (en) * 1996-02-02 1999-11-11 Merck & Co., Inc. Method of treating diabetes and related disease states
CA2315397C (en) * 1997-12-19 2007-08-07 Merck & Co., Inc. Arylthiazolidinedione derivatives
DE60029446T2 (de) * 1999-06-18 2007-02-08 Merck & Co., Inc. Arylthiazolidindione und aryloxazolidindion-derivate
GB9914977D0 (en) 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
GB0003310D0 (en) * 2000-02-15 2000-04-05 Univ Sheffield Bone formation
CN1537093A (zh) * 2001-07-30 2004-10-13 ŵ��Ų�ڿ˹�˾ 新乙烯基羧酸衍生物以及它们作为抗糖尿病等药物的用途
AU2003224632A1 (en) 2002-03-01 2003-09-16 Smithkline Beecham Corporation Hppars activators
WO2005019151A1 (en) 2003-08-20 2005-03-03 Eli Lilly And Company Ppar modulators
US7301050B2 (en) * 2003-09-19 2007-11-27 Janssen Pharmaceutical N.V. 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
MY145712A (en) 2004-09-15 2012-03-30 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
MY147518A (en) 2004-09-15 2012-12-31 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
JO3006B1 (ar) * 2005-09-14 2016-09-05 Janssen Pharmaceutica Nv املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك

Also Published As

Publication number Publication date
EP1670744B9 (en) 2012-09-05
ES2349143T3 (es) 2010-12-28
PT2243766E (pt) 2015-10-20
ZA200603084B (en) 2007-09-26
AU2004276231B2 (en) 2010-07-01
EA009119B1 (ru) 2007-10-26
HUE028213T2 (en) 2016-12-28
EP2243766A2 (en) 2010-10-27
DK1670744T5 (da) 2012-11-26
CA2539403A1 (en) 2005-04-07
CO5680473A2 (es) 2006-09-29
TWI330630B (en) 2010-09-21
CY1117666T1 (el) 2017-05-17
PL2243766T3 (pl) 2016-02-29
PL1670744T3 (pl) 2011-01-31
AU2004276231A1 (en) 2005-04-07
EP1670744B1 (en) 2010-08-04
DK1670744T3 (da) 2010-11-08
CR8303A (es) 2008-09-10
US8450371B2 (en) 2013-05-28
WO2005030694A1 (en) 2005-04-07
US20100004470A1 (en) 2010-01-07
US8008513B2 (en) 2011-08-30
US20050107469A1 (en) 2005-05-19
DE602004028500D1 (de) 2010-09-16
NZ545971A (en) 2009-09-25
DK2243766T3 (en) 2015-10-12
AR045774A1 (es) 2005-11-09
PT1670744E (pt) 2010-09-27
SI2243766T1 (sl) 2015-12-31
EA200600439A1 (ru) 2006-08-25
KR20060094959A (ko) 2006-08-30
IL174399A (en) 2013-11-28
CN1882524A (zh) 2006-12-20
ATE476408T1 (de) 2010-08-15
US20110294875A1 (en) 2011-12-01
EP2243766B1 (en) 2015-09-02
UA87468C2 (en) 2009-07-27
TW200526562A (en) 2005-08-16
BRPI0414534B8 (pt) 2021-05-25
JP5016922B2 (ja) 2012-09-05
BRPI0414534B1 (pt) 2019-01-08
ES2349143T9 (es) 2012-12-07
ES2555031T3 (es) 2015-12-28
US8258177B2 (en) 2012-09-04
CY1110847T1 (el) 2015-06-10
CN1882524B (zh) 2011-06-08
KR101094742B1 (ko) 2011-12-16
HK1093060A1 (en) 2007-02-23
BRPI0414534A (pt) 2006-11-07
CA2539403C (en) 2013-11-19
JP2007505907A (ja) 2007-03-15
IL174399A0 (en) 2006-08-01
SI1670744T1 (sl) 2010-11-30
EP2243766A3 (en) 2011-02-16
SG149041A1 (en) 2009-01-29
EP1670744A1 (en) 2006-06-21
NO337041B1 (no) 2016-01-11
US7598292B2 (en) 2009-10-06
US20120322875A1 (en) 2012-12-20
ECSP066435A (es) 2006-09-18

Similar Documents

Publication Publication Date Title
NO20061711L (no) 4-((fenoksylalkyl)tio)fenoksyeddiksyre og analoger
NO20061728L (no) 4-((fenoksyalkyl)tio)-fenolsueddiksyre og analoger
NO20071919L (no) 4-((fenoksyalkyl)tio)-fenoksyeddiksyre og analoger
NO20071920L (no) 4-((fenoksyalkyl)tio)-fenoksyeddiksyre og analoger
NO20062511L (no) Fenoksy-eddiksyrederivater anvendelige som peroksisomproliferator-aktiverende reseptor (PPAR) dualagonister
NO20081196L (no) Terapeutisk middel for diabetes
NO20090235L (no) Kondenserte sykliske forbindelser
NO20085031L (no) Benzimidazolmodulatorer av VR1
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
NO20071222L (no) Benzamidforbindelser.
UY28127A1 (es) Nuevos enantiomeros (r) y (s) de derivados del acido tiofeno hidroxamico
DK1670778T3 (da) Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende
NO20054408D0 (no) 3(2-fenyl-oksazol-4-yl-metoksy)-cykloheksylmetoksyeddiksyrederivater og lignende forbindelser som PPAR-modulatorer for behandling av type 2 diabetes og arterosklerose
NO20052277L (no) Behandling av syndrom X med substituerte tetraliner og indaner
WO2003064384A3 (en) Environment friendly reagents and process for trifluoromethylsulfinylation of organic compounds
NO20081948L (no) Heksahydro-cykloheptapyrazol cannabinoide modulatorer
DK1554240T3 (da) Substituerede tetraliner og indaner og deres anvendelse
NO20052199L (no) Substituerte tetraliner og indaner